The difference and selection between coagulant suspension and dry powder

In the additive system of vacuum blood collection tubes, blood coagulants play an important role in accelerating blood coagulation and shortening the sample processing cycle. At present, the common forms of coagulant products on the market mainly include suspension and dry powder. Although the two have the same effect on coagulation function, there are clear differences in usage, storage and transportation, and operational convenience. Understanding these differences can help blood collection tube manufacturers make reasonable choices based on their own process conditions.

The essential differences between the two forms

Blood coagulants, whether in suspension or dry powder form, have the same active ingredients that promote coagulation. Unlike water-soluble anticoagulants such as EDTA dipotassium and heparin, coagulants have a more complex composition system, with some components having limited solubility in water or organic solvents. When the coagulant is dispersed in a liquid medium, it does not form a homogeneous true solution, but rather suspends in the solvent in the form of small particles, forming a suspension. The particle size of these dispersed particles is relatively large, and they will settle or stratify under the influence of gravity under static conditions.

The coagulant powder is provided in the form of a dry powder of active ingredients, without any dispersing medium. The powder form itself does not have direct additive convenience and usually needs to be prepared into a suspension before use. But in international long-distance transportation or scenarios that require long-term storage, the advantages of dry powder form are reflected - it does not contain liquid media, there is no risk of volatilization, stratification or freezing, and it has a stronger tolerance to environmental conditions during storage and transportation.

Process adaptability of suspension

The coagulant suspension does not require additional preparation during use and can be directly added to the blood collection tube, eliminating the steps of weighing, dissolving, and preparing, making it suitable for large-scale assembly line operations. In the highly automated blood collection tube production line, using suspension can simplify the operation process, reduce manual intervention, and improve production consistency and efficiency. But the suspension needs to be shaken thoroughly before use to ensure that the coagulant particles dispersed in the liquid medium are evenly distributed in the system. This is because the suspension will precipitate or stratify in a static state. If it is taken directly without mixing, the amount of coagulant added will vary within the batch.

Considerations for Transportation and Warehousing

For blood collection tube production enterprises, the stability of the supply chain and logistics costs are important selection factors. The coagulation powder does not contain liquid medium, and the proportion of active ingredients per unit weight is higher. Products of the same weight contain more effective components, with smaller packaging volume and lighter transportation weight. At the same time, the dry powder form does not need to consider the volatilization, freezing, or stratification issues caused by temperature changes in the liquid medium during transportation, and the shelf life is usually longer.
The coagulant suspension contains a considerable proportion of liquid medium, and the proportion of active ingredients in the unit packaging is relatively low. Under the same effective amount, the transportation weight and volume will increase. If there are severe temperature fluctuations during transportation, the stability of the suspension may be affected, and more careful control of transportation conditions is required.

Operation requirements before use

Regardless of the form used, coagulants need to undergo certain processing steps before use. The suspension needs to be shaken well before use; Dry powder needs to be prepared into a suspension before use. At present, there is a process of directly spraying coagulation promoting powder, but its application scope is relatively limited. Most blood collection tube production lines still prefer to pre prepare coagulation promoting powder as a suspension before use. During the preparation process, it is necessary to control the dosage ratio and dispersion uniformity to ensure that the prepared suspension meets the requirements for use.

There is no absolute good or bad choice for the form of coagulant, the key lies in whether it matches the process flow of the production line. For production scenarios that require simplifying operational processes and improving production efficiency, suspension is a more direct choice; For scenarios that require long-term reserves, international transportation, or bulk allocation, the dry powder form provides greater flexibility. Hubei Xindesheng Material Technology Co., Ltd. can provide two forms of coagulant products to meet the process preferences and operating conditions of different blood collection tube production enterprises. If you need them, you can click on the official website to learn more details!